Anna Lissina
Paris, 75013, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8+ T-cell responses in vitro.
Journal: Scientific reports
Published: February 18, 2020
Priming of HIV-1-specific CD8+ T cells with strong functional properties from naïve T cells.
Journal: EBioMedicine
Published: November 16, 2018
Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors.
Journal: Science immunology
Published: July 16, 2017
TCR clonotypes: molecular determinants of T-cell efficacy against HIV.
Journal: Current opinion in virology
Published: September 18, 2015
Reduced naïve CD8(+) T-cell priming efficacy in elderly adults.
Journal: Aging cell
Published: June 30, 2015
Fine-tuning of CD8(+) T-cell effector functions by targeting the 2B4-CD48 interaction.
Journal: Immunology and cell biology
Published: June 29, 2015
Priming of Qualitatively Superior Human Effector CD8+ T Cells Using TLR8 Ligand Combined with FLT3 Ligand.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 15, 2015
Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells.
Journal: Clinical and experimental immunology
Published: March 12, 2014
The link between CD8⁺ T-cell antigen-sensitivity and HIV-suppressive capacity depends on HLA restriction, target epitope and viral isolate.
Journal: AIDS (London, England)
Published: January 04, 2014
T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting.
Journal: The Journal of biological chemistry
Published: September 07, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026